Intellia Therapeutics, Inc. (NTLA)
11.21
+0.05
(+0.45%)
USD |
NASDAQ |
Oct 23, 16:00
11.15
-0.06
(-0.54%)
After-Hours: 20:00
Intellia Therapeutics Price : 11.21 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 11.00 | 11.24 | 10.58 | 11.21 | 3.567M |
| Oct 22, 2026 | 11.41 | 11.96 | 10.98 | 11.16 | 3.651M |
| Oct 21, 2026 | 11.84 | 11.91 | 11.55 | 11.65 | 2.829M |
| Oct 20, 2026 | 11.46 | 12.00 | 11.28 | 11.84 | 3.417M |
| Oct 19, 2026 | 11.54 | 11.85 | 11.33 | 11.58 | 3.505M |
| Oct 16, 2026 | 11.60 | 11.68 | 10.91 | 11.42 | 8.236M |
| Oct 15, 2026 | 11.33 | 11.82 | 11.10 | 11.34 | 6.529M |
| Oct 14, 2026 | 11.83 | 11.87 | 11.28 | 11.43 | 5.439M |
| Oct 13, 2026 | 12.30 | 12.48 | 11.82 | 11.91 | 5.180M |
| Oct 12, 2026 | 13.08 | 13.23 | 12.56 | 12.58 | 4.380M |
| Oct 09, 2026 | 12.36 | 13.27 | 11.93 | 13.07 | 8.155M |
| Oct 08, 2026 | 11.90 | 12.64 | 11.76 | 12.60 | 13.97M |
| Oct 07, 2026 | 12.08 | 12.41 | 11.70 | 11.71 | 8.298M |
| Oct 06, 2026 | 12.50 | 13.22 | 12.04 | 12.37 | 7.952M |
| Oct 05, 2026 | 12.35 | 12.88 | 11.85 | 12.75 | 4.968M |
| Oct 02, 2026 | 12.42 | 12.76 | 12.10 | 12.26 | 4.504M |
| Oct 01, 2026 | 11.98 | 12.66 | 11.82 | 12.12 | 7.448M |
| Sep 30, 2026 | 11.96 | 12.24 | 11.75 | 12.06 | 5.318M |
| Sep 29, 2026 | 11.49 | 12.05 | 11.42 | 12.03 | 5.018M |
| Sep 28, 2026 | 11.72 | 11.80 | 11.33 | 11.42 | 3.300M |
| Sep 25, 2026 | 12.33 | 12.33 | 11.66 | 11.75 | 2.986M |
| Sep 24, 2026 | 12.13 | 12.21 | 11.62 | 12.16 | 4.809M |
| Sep 23, 2026 | 12.72 | 12.85 | 11.96 | 12.33 | 5.042M |
| Sep 22, 2026 | 12.27 | 12.97 | 12.14 | 12.69 | 3.921M |
| Sep 21, 2026 | 12.50 | 12.65 | 12.14 | 12.22 | 3.739M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 139.92 |
| Beam Therapeutics, Inc. | 24.05 |
| Prime Medicine, Inc. | 3.67 |
| 10X Genomics, Inc. | 71.55 |
| Moderna, Inc. | 200.10 |
Price Related Metrics
| PS Ratio | 22.52 |
| Price to Book Value | 2.157 |
| Earnings Yield | -29.95% |
| Market Cap | 1.570B |